Recent News

• 12.12.2025 - Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
• 12.12.2025 - Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer’s Trial
• 12.02.2025 - Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
• 12.02.2025 - Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company
• 11.25.2025 - Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
• 11.25.2025 - Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
• 11.13.2025 - Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference
• 11.13.2025 - Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference

Recent Filings

• 12.12.2025 - FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
• 12.12.2025 - EX-99.1 EX-99.1
• 12.12.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.12.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 12.10.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 12.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 12.02.2025 - EX-99.1 EX-99.1
• 11.25.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 11.25.2025 - EX-99.1 EX-99.1
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors